首页> 外文期刊>Bulletin of Clinical Psychopharmacology >Schizophrenia and other psychotic disorders Fractional anisotropic changes of the corpus callosum associated with antipsychotic treatment in first-episode antipsychotic drug-naive patients with schizophrenia
【24h】

Schizophrenia and other psychotic disorders Fractional anisotropic changes of the corpus callosum associated with antipsychotic treatment in first-episode antipsychotic drug-naive patients with schizophrenia

机译:精神分裂症和其他精神病性疾病首发抗精神病药物初治型精神分裂症患者中与抗精神病药物治疗相关的call体的分数各向异性变化

获取原文
       

摘要

BACKGROUND: Schizophrenia is a serious brain illness that indicates many abnormalities in the functions of the brain’s fiber connections such as assessing the reality, thought, emotion and cognition. These fibers effect cognitional functions by connecting cortical and subcortical areas and networks formed by them. Aberrant brain connectivity especially in the prefrontal and temporal heteromodal cortex has been suggested as the essential mechanism underlying the disease. In this study, it is intended to investigate the post- and pre-treatment changes with diffusion tensor imaging MRI (DTI-MRI) in the splenium and genu regions of the corpus callosum in patients diagnosed with first-episode schizophrenia according to the DSM-IV-TR. METHOD: Between June 2009 and February 2010, 18 patients with psychotic symptoms were recruited from the outpatient unit of the GMMA Haydarpasha Research and Training Hospital. These patients had been diagnosed with first-episode schizophrenia (n=7) or schizophreniform disorder (n=11) and matched inclusion criteria. Patients with schizophreniform disorder as initial diagnosis were reevaluated after 6 months, and this time schizophrenia diagnosis was a ascertained. By means of implementation of SCID-II, additional diagnoses for personality disorder were excluded. Two of the 18 patients who had been admitted to the study were excluded because of being diagnosed with short-term psychotic disorder, and two patients were unable to proceed because of incompatibilitywith MRI device. Three participants with schizophrenia were excluded from this study because of unsatisfactory image data due to head and body movement in the follow-up MRI scan. DTI-MRI was obtained from participants at baseline and after 4 weeks of standard antipsychotic treatment follow-up. A ‘difference color-coded fractional anisotropy (FA) map’ for each of the 11 patients was calculated from the 4-week follow-up and the baseline splenium and genu FA ROI (Region of Interest)-based measurements. Finally, this study included participants of whom 14 had completed baseline, 11 both baseline and follow-up experiment and 16 control persons who had no organic or psychiatric disease and whose age, sex and education level was matched with the patient group. Patients included in the study were hospitalized, all tests and measurements were implemented before starting on antipsychotics, then standard antipsychotic treatments (Risperidone (n=12), Paliperidone (n=2)) were continued. Patients’ family histories were received and they were examined mentally, physically and neurologically. Initially liver, kidney and thyroid functions of all patients were examined. In addition, structural brain abnormalities were evaluated during the DTI measurements. To be eligible, criteria of involvement for either patients or healthy control subjects were: between 18 and 45 years old, being right-handed, first application to psychiatry, at least primary school graduate, no abuse of nicotine or caffeine, no DSM-IV-TR Axis I and Axis II comorbidity, a written consent (for patients by first-degree relatives). Criteria for being excluded: clinically conspicuous medical or neurological illness, having received antipsychotic treatment at the time of application or before or having used benzodiazepine longer than two weeks, for necessity of ECT (Electroconvulsive therapy), an incompatibility with MRI device and communication because of language problems and illnesses. The study was started after submitting the study protocol to the Istanbul Clinical Research Ethics Board and receiving approval from there (Number of decision: 2009-CC-040/11.12.2009) DTI Image Analysis: FA maps were calculated with Siemens? syngo VE27A SL0109 Syngo Multimodality Workplace AG 2007 according to Basser et al. Major eigenvector linear maps were transformed into color codes. In the second stage, in advance of measurements 3D correction (Eddy Current Correction) was implemented to remove artifacts of emerging images. ROI radiuses were determined as 2 mm in the genu, 3 mm in the splenium. Hereby FA values were calculated accurately. Statistic Evaluation: Acquired parameters from the study were evaluated with Statistical package for Social Sciences for Windows 16.0 (SPSS 16.0). Study parameters were expressed with average±standard deviation and percentage values. Group differences were assessed at baseline using independent group Student’s t-tests or χ2-tests, whereas longitudinal changes between the baseline and follow-up time points in the patients’ group was examined using paired Student’s t-tests. Significance level was based on p0.05). First-episode schizophrenia group’s economic level was lower than in healthy controls (χ2=5.275, p=0.022). DUP was identified as 2.3±1.7 months. Family history for schizophrenia was identified as 28.6%. In the first-episode schizophrenia group, an FA value of the genu region of the corpus callosum was determined as 0.690±0.124 and 0.834±0.042 for th
机译:背景:精神分裂症是一种严重的脑部疾病,表明大脑纤维连接功能的许多异常,例如评估现实,思想,情感和认知。这些纤维通过连接皮质和皮质下区域以及由它们形成的网络来影响认知功能。异常的大脑连通性,特别是在额额叶和颞部的异质皮质中,被认为是该疾病的基本机制。在这项研究中,本研究旨在根据DSM-MS对被诊断为首发精神分裂症的患者的diffusion体脾和属区的弥散张量成像MRI(DTI-MRI)进行调查,研究其治疗前后的变化。 IV-TR。方法:从2009年6月至2010年2月,从GMMA Haydarpasha研究培训医院的门诊部招募了18例精神病患者。这些患者被诊断出患有首发精神分裂症(n = 7)或精神分裂症样疾病(n = 11),并符合纳入标准。 6个月后重新评估患有精神分裂症样疾病的患者作为初始诊断,这一次可以确定精神分裂症的诊断。通过实施SCID-II,排除了其他人格障碍的诊断。入选本研究的18例患者中有2例由于被诊断为患有短期精神病而被排除在外,还有2例患者由于与MRI设备不兼容而无法进行治疗。由于在后续MRI扫描中头部和身体运动导致图像数据不理想,因此将三名精神分裂症患者排除在本研究之外。在基线和标准抗精神病药物治疗4周后,从参与者处获得DTI-MRI。根据4周的随访以及基于基线的脾和膝FA ROI(感兴趣区域)的测量结果,计算出11位患者中每位患者的“差异色码分数各向异性(FA)图”。最后,这项研究包括参与者,其中14名已完成基线,11名基线和后续实验以及16名无器质性或精神疾病且年龄,性别和教育水平与患者组相匹配的对照组。纳入研究的患者均已住院,在开始使用抗精神病药之前已进行了所有测试和测量,然后继续使用标准抗精神病药物(利培酮(n = 12),帕潘立酮(n = 2))。接收患者的家族病史,并对他们进行心理,身体和神经方面的检查。最初检查所有患者的肝,肾和甲状腺功能。此外,在DTI测量期间评估了大脑结构异常。为符合资格,患者或健康对照组的参与标准为:18至45岁之间,惯用右手,首次申请精神病学,至少是小学毕业生,没有滥用尼古丁或咖啡因,没有DSM-IV -TR第一轴和第二轴合并症,书面同意书(适用于一级亲属的患者)。排除标准:临床上明显的医学或神经系统疾病,在应用时或之前或之前使用苯二氮卓类药物进行抗精神病治疗超过两周,由于需要ECT(电惊厥疗法),与MRI设备不兼容以及由于以下原因导致的沟通障碍语言问题和疾病。在向伊斯坦布尔临床研究伦理委员会提交研究方案并获得伊斯坦布尔方案批准后开始研究(决定号:2009-CC-040 / 11.12.2009)DTI图像分析:FA图是使用Siemens计算的?根据Basser等人的说法,syngo VE27A SL0109 Syngo Multimodality Workplace AG 2007。主要特征向量线性图被转换为颜色代码。在第二阶段中,在测量之前执行3D校正(涡流校正)以去除新兴图像的伪像。 ROI半径确定为2 mm,脾脏3 mm。从而精确计算FA值。统计评估:使用Windows 16.0(SPSS 16.0)的Social Sciences统计软件包对研究中获得的参数进行评估。研究参数以平均值±标准偏差和百分数表示。使用独立的小组学生t检验或χ2检验在基线时评估组间差异,而使用配对的学生t检验检查患者组基线和随访时间点之间的纵向变化。显着性水平基于p0.05)。首发精神分裂症患者的经济水平低于健康人(χ2= 5.275,p = 0.022)。 DUP被确定为2.3±1.7个月。精神分裂症的家族史被确定为28.6%。在第一期精神分裂症组中,call体的属区的FA值被确定为0.690±0.124和0.834±0.042。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号